Variables (n = 62) | n (%) |
---|---|
Clinical staging | |
0 | 3 (4.8) |
I | 20 (32.3) |
II | 28 (45.2) |
III | 11 (17.7) |
Histological subtype | |
Invasive breast carcinoma | 40 (64.5) |
Invasive ductal carcinoma | 6 (9.7) |
In situ ductal carcinoma | 3 (4.8) |
Special subtypes | 13 (21.0) |
Diagnosis time (months) | |
< 6 | 51 (82.3) |
6 – 12 | 11 (17.7) |
Type of treatment | |
No previous treatment | 29 (46.8) |
Neoadjuvant | 10 (16.1) |
Surgical | 9 (14.5) |
Adjuvant | 14 (22.6) |
Menopausal status | |
Pre-menopause | 11 (17.7) |
Post-menopause | 51 (82.3) |
Menopause time (years)1 | |
≤ 15 | 27 (52.9) |
> 15 | 24 (47.1) |